RTW Venture Fund LTD.

For assistance please contact
RTWVentureK1Help@deloitte.com
Tel: 833-265-8676 (toll free)

About Us

Overview

RTW Venture Fund Limited (the “Company” or LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Our approach is driven by applying deep scientific expertise with a long-term investment horizon. The Company is managed by RTW Investments, LP (the “Investment Manager”), a leading healthcare-focused entrepreneurial investment firm with a track record of supporting companies developing life-changing therapies.

Board of Directors

William Scott

Chairman of the Nomination and Remuneration Committee
William Scott

Chairman of the Nomination and Remuneration Committee

William Scott serves as an independent non-executive director of a number of investment companies and funds. From 2003 to 2004, Mr. Scott worked as Senior Vice President with FRM Investment Management Limited, now part of Man Group. Previously (from 1989–2002), Mr. Scott was a portfolio manager and latterly a director at Rea Brothers (which became part of the Close Brothers group in 1999 and where he was a director of Close Bank Guernsey Limited) and before that Assistant Investment Manager with the London Residuary Body Superannuation Scheme (1987-1989). Mr. Scott graduated from the University of Edinburgh in 1982 and is a Chartered Accountant having qualified with Arthur Young (now EY) in 1987. Mr. Scott also holds the Securities Institute Diploma and is a Chartered Fellow of the Chartered Institute for Securities & Investment. He is also a Chartered Wealth Manager. His other directorships include Axiom European Financial Debt Fund Limited and Worsley Investors Limited, both of which are listed on the Premium Segment of the London Stock Exchange.

Stephanie A. Sirota

Non-executive Director
Stephanie A. Sirota

Non-executive Director

Stephanie A. Sirota, serves as a Partner and Chief Business Officer at RTW Investments, LP. Ms. Sirota is responsible for strategy and oversight of the firm’s business development, strategic partnerships, communications, and investor relations. Her background in investment banking and expertise in financial markets has helped position the firm as both a partner to life sciences companies and a steward of investors’ capital. She also manages RTW’s relationships with key partners including banks, academic institutions, corporations, investors, and NGOs and has led the firm’s entry into the UK and European markets. Ms. Sirota has a decade of deal experience in financial services. Prior to joining the Investment Manager, from 2006 to 2010, she served as a director at Valhalla Capital Advisors, a macro and commodity investment manager. From 2000 to 2003, Ms. Sirota worked in the New York and London offices of Lehman Brothers, where she advised on various mergers and acquisitions, IPOs, and capital market financing transactions with a focus on cross-border transactions for the firm’s global corporate clients. She began her career on the Fixed Income trading desk at Lehman Brothers, structuring derivatives for municipal issuers from 1997 to 1999. Ms. Sirota graduated with honours from Columbia University and also received a Master’s Degree from the Columbia Graduate School of Journalism. She has contributed to Fortune Magazine and ABCNews. com and is a supporter of the arts, science, and children’s initiatives. She serves as Co-Chairman of the Council of the Phil at the New York Philharmonic and as President of RTW Charitable Foundation. Ms. Sirota serves as Vice President of Corporate Strategy and Corporate Communications of Health Sciences Acquisitions Corporation 2 (HSAC2) and served in the same role at Health Sciences Acquisitions Corporation (HSAC) until December 2019.

Paul LePage

Chairman of the Audit Committee
Paul LePage

Chairman of the Audit Committee

Paul Le Page is a former Executive Director and Senior Portfolio Manager of FRM Investment Management Limited, a subsidiary of Man Group, and holds non-executive directorships at a number of London Stock Exchange listed investment funds. Mr. Le Page is Audit Committee Chair of Bluefield Solar Income Fund Limited and was previously Audit Committee Chair of UK Mortgages Limited, Thames River Multi Hedge PCC Limited and Cazenove Absolute Equity Limited. Mr. Le Page has 18 years’ Audit Committee chair experience within the
closed end investment fund sector and has a broad-based knowledge of the global investment industry and product structures. Mr. Le Page graduated from University College London and later received an MBA from Heriot Watt University. He originally qualified as a Chartered Engineer and led the development of clinical diagnostic instrumentation and software and robotic sample preparation equipment prior to commencing a career in finance.

William Simpson

Chairman
William Simpson

Chairman

William Simpson is the Chairman and an independent director based in Guernsey providing services to investment and other financial services companies. William has over 30 years’ experience within the financial services industry. He previously practiced law in the course of which he advised on the establishment of a wide range of investment funds and related matters. William graduated in law from Leeds University and first qualified as an English barrister. William is a member of the Guernsey Bar. William also holds directorships at Ninety One Premier Funds PCC Limited, Handelsbanken Alternatives Fund Limited, AHL Strategies PCC Limited, Man AHL Diversified PCC Limited and Alpha Real Trust Limited.

INVESTOR FINANCIALS

SHARE PRICE CENTER

INVESTOR BULLETIN

RNS & INSIDE INFORMATION

RNS Email Alerts

INVESTOR INFORMATION

Results Center

31 March 2022 Annual Report and Audited Financial Statements 2021 (3.6MB)
31 March 2022 Annual Report 2021 Presentation (2.24MB)
16 September 2021 June 2021 Half-Yearly Report and Financial Statements (2.27MB)
29 April 2021 Annual Report and Audited Financial Statements 2020 (8.18MB)
24 September 2020 June 2020 Half-Yearly Report and Financial Statements (2 MB)
22 April 2020 Annual Report and Audited Financial Statements 2019 (3.03MB)

DOCUMENT LIBRARY

26 Jul 2022 Fact Sheet Q2 2022 (413KB)
17 May 2022 Form of Proxy 2022 (38KB)
17 May 2022 Notice of Annual General Meeting 2022 (55KB)
28 Apr 2022 Fact Sheet Q1 2022 (381KB)
27 Apr 2022 Key Information Document (207KB)
24 Jan 2022 Fact Sheet Q4 2021 (359KB)
7 Jan 2022 RTW Venture Fund Presentation Nov 2021 (2MB)
26 Oct 2021 Fact Sheet Q3 2021 (338KB)
6 Aug 2021 Articles of Incorporation (644KB)
2 Aug 2021 Fact Sheet Q2 2021 (315KB)
14 July 2021 Circular 14 July 2021 (330KB)
14 July 2021 JPMC Consent Letter (143KB)
1 June 2021 Notice of Annual General Meeting 2021 (122KB)
1 June 2021 Form of Proxy (442KB)
28 April 2021 Fact Sheet Q1 2021 (318KB)
22 January 2021 Fact Sheet Q4 2020 (446KB)
19 October 2020 Fact Sheet Q3 2020 (695KB)
21 July 2020 Fact Sheet Q2 2020 (589KB)
26 June 2020 AGM Shareholder Q&A (102KB)
29 May 2020 Nomination Remuneration Committee Terms of Reference (122KB)
29 May 2020 MEC Terms of Reference (123KB)
16 April 2020 Fact Sheet Q1 2020 (538KB)
5 March 2020 Audit Committee Terms of Reference (97.9KB)
REGULATORY
7 February 2020
Investor Disclosure Document (154KB)
14 October 2019 GDPR Compliant Privacy Policy (117KB)
14 October 2019 Launch Announcement (465KB)
14 October 2019 Prospectus (2.36MB)
14 October 2019 Prospectus Summary (276KB)
14 October 2019 Articles of Incorporation (470KB)

INQUIRIES

INVESTOR & MEDIA INQUIRIES

Stephanie Sirota — Chief Business Officer
T: +1.646.597.6980
E: sas@rtwfunds.com

SHAREHOLDER INQUIRIES

Corporate Governance

The Board recognises the value of sound corporate governance and, in particular, has regard to the requirements of the UK Code (available from the FRC’s website).

The Company is a registered closed-ended investment scheme pursuant to the Protection of Investors (Bailiwick of Guernsey) Law, 1987, as amended, and the Registered Collective Investment Schemes Rules 2015 issued by the GFSC. The GFSC has issued a Finance Sector Code of Corporate Governance (“GFSC Code”) that applies to all companies that hold a licence from the GFSC under the regulatory laws or which are registered or authorised as Collective Investment Schemes, which includes the Company. The GFSC has stated in the GFSC Code that companies which report against the UK Code or the AIC Code are deemed to meet their code, and need take no further action.

The Company’s prospectus dated 14 October 2019 stated that the Company will be in compliance with the UK Code. The Company became a member of the AIC on listing and the Board of the Company has accordingly considered, and resolved to follow, the principles and recommendations of the AIC Code (available from the AIC’s website).

The AIC Code addresses all the principles set out in the UK Code, as well as setting out additional principles and recommendations on issues that are of specific relevance to investment companies such as the Company. The Board considers that reporting against the principles and recommendations of the AIC Code (which incorporates the UK Code) provides better information to shareholders whilst meeting the requirements of the GFSC Code.

In respect of the period from re-domiciliation until 30 October 2019, the date of admission to the SFS, the Company substantially complied in all material respects with the relevant provisions of the GFSC Code. As from the date of initial admission, the Company has voluntarily committed to comply with the 2019 AIC Code.

The Company currently complies with the principles and provisions of the AIC code.

For the reasons set out in the preamble to the UK Code, the Board considers certain of these provisions are not relevant to the position of the Company as an externally managed investment company. In particular all of the Company’s day-to-day management and administrative functions are outsourced to third parties. As a result, the Company has no chief executive or any executive directors, employees or internal operations and has therefore not reported further in respect of these provisions.

Provision 14 of the AIC Code states a Board should consider appointing one independent non-executive Director to be the Senior Independent Director. The Board, having taken into account its small size and that the Chairman and two of the other three Directors are each similarly independent and non-executive, considers it unnecessary to appoint such a Senior Independent Director. All members of the Board are available to shareholders if they have unresolved concerns.

The need for an internal audit function is discussed in the Report of the Audit Committee.

No Access

You are not eligible to access the information included in this website

THIS WEBSITE IS NOT INTENDED TO OFFER OR TO PROMOTE THE OFFER OR SALE OF THE SHARES (THE “SHARES”) OF RTW VENTURE FUND LIMITED (THE “COMPANY”) IN THE UNITED STATES OR TO ANY “U.S. PERSONS” AS DEFINED IN REGULATION S (“US PERSONS”) UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THE MATERIALS CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO ANY PERSONS TO WHOM OR INTO OR WITHIN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW OR REGULATION.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance.The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States or who are US Persons or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.

Access our Annual Results 2019 Presentation Recording

  • This field is for validation purposes and should be left unchanged.